Commentary on "accounting for the interim safety monitoring of an adverse event upon termination of a clinical trial"
Journal
Journal of Biopharmaceutical Statistics
Journal Volume
18
Journal Issue
4
Pages
641-643
Date Issued
2008
Author(s)
Other Subjects
cerivastatin; rofecoxib; clinical trial; drug efficacy; drug industry; drug safety; human; monitoring; note; priority journal; risk assessment; risk management; unspecified side effect
Type
journal article